Clinical trial
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
NCT04688190 · Universitätsklinikum Hamburg-Eppendorf, Other · Recruiting
Key facts
| NCT number | NCT04688190 |
|---|---|
| Title | CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry |
| Official title | Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry |
| Acronym | CHOICE-MI |
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf, Other |
| Collaborators | Montreal Heart Institute University Hospital, Bordeaux |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Mitral Regurgitation |
| Enrollment | 800 |
| Start date | Nov 1, 2020 |
| Primary completion | Mar 1, 2025 |
| Completion | Dec 31, 2030 |
| First posted | Dec 29, 2020 |
| Last update posted | May 17, 2022 |
| Countries | Australia, Canada, Denmark, France, Germany, Italy, Norway, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: